1. Home
  2. IMMP vs BNTC Comparison

IMMP vs BNTC Comparison

Compare IMMP & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immutep Limited

IMMP

Immutep Limited

SELL

Current Price

$3.36

Market Cap

31.5M

Sector

Health Care

ML Signal

SELL

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

N/A

Current Price

$7.92

Market Cap

315.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IMMP
BNTC
Founded
1987
1995
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.5M
315.4M
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
IMMP
BNTC
Price
$3.36
$7.92
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $23.75
AVG Volume (30 Days)
30.6K
★ 154.2K
Earning Date
09-01-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 6.67
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.26
$7.89
52 Week High
$5.36
$14.39

Technical Indicators

Market Signals
Indicator
IMMP
BNTC
Relative Strength Index (RSI) 49.75 37.62
Support Level $3.06 N/A
Resistance Level $3.55 $13.87
Average True Range (ATR) 0.34 0.66
MACD -0.05 -0.08
Stochastic Oscillator 41.09 5.18

Price Performance

Historical Comparison
IMMP
BNTC

About IMMP Immutep Limited

Immutep Ltd is a clinical-stage biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

Share on Social Networks: